Inotek Pharma Reports Publication of Phase 1 Data for Trabodenoson in JOPT

By: via Benzinga
Inotek Pharmaceuticals Corporation (the "Company" or "Inotek") (NASDAQ: ITEK), a clinical-stage biopharmaceutical company focused on ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.